双时间点18F-氟胆碱PET/CT改善原发性甲状旁腺功能亢进患者的甲状腺结节表征:一项概念验证研究
本研究纳入27例原发性甲状旁腺功能亢进(pHPT)伴甲状腺结节(>10 mm)患者共32个结节,行双时间点18F-FCH PET/CT(注射后5和60分钟),计算结节/甲状腺SUVmax比值及洗脱指数(WO%)。恶性病变早期摄取比值显著高于良性(P=0.0008),WO%在良恶性间差异显著(2.9%±4.1% vs 45.5%±13.4%,P=0.0001);以WO%阈值22.1%分类,灵敏度100%、特异度92.6%、阳性预测值71.4%、阴性预测值100%,假阳性为2例NIFTP。
要点
- pHPT患者甲状腺结节恶性者早期18F-FCH摄取比值显著高于良性(P=0.0008)。
- 恶性结节洗脱指数显著高于良性(45.5%±13.4% vs 2.9%±4.1%,P=0.0001)。
- WO%阈值22.1%分类灵敏度100%、特异度92.6%、阴性预测值100%。
核心结论
- 初步结果提示对pHPT伴未表征的厘米级甲状腺结节患者可行双时间点18F-FCH PET/CT采集协议。
- 这些有希望的结果的真实影响需通过更大 cohort 的前瞻性研究评估。
研究设计与样本
- 仅纳入甲状腺结节>10 mm且有病理分析(金标准)者,共27例患者32个结节。
- 计算两个时间点的结节/甲状腺SUVmax比值及18F-FCH洗脱指数(WO%)。
主要发现
- 最终诊断:27个良性结节(含2例NIFTP)和5个滤泡起源癌。
- 恶性病变早期摄取比值显著高于良性结节(P=0.0008)。
- 甲状腺癌洗脱指数显著高于良性(WO%良性 vs 癌:2.9%±4.1% vs 45.5%±13.4%,P=0.0001)。
- 以WO%阈值22.1%分类,25/27良性结节和5/5恶性病变被准确分类。
- 假阳性与2例NIFTP有关,其与甲状腺癌有相似特征。
关键数值与推荐
- WO%阈值22.1%:灵敏度100%、特异度92.6%、阳性预测值71.4%、阴性预测值100%。
- 纳入标准:甲状腺结节>10 mm且有病理分析(金标准)。
- 双时间点采集:注射后5和60分钟。
临床怎么用
- 对pHPT伴未表征的厘米级甲状腺结节患者,可考虑行双时间点18F-FCH PET/CT采集以辅助鉴别良恶性。
- WO%可作为鉴别甲状腺结节良恶性的参考指标,但需注意NIFTP可能导致假阳性。
局限性
- 本研究为初步概念验证,样本量小(27例患者32个结节)。
- 假阳性与2例NIFTP有关,其与甲状腺癌特征相似。
- 真实影响需通过更大 cohort 的前瞻性研究评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Thyroid nodules frequently coexist with primary hyperparathyroidism (pHPT). Because of the increasing use of 18F-fluorocholine (18F-FCH) PET/CT in patients with pHPT, evaluation of its clinical utility for thyroid nodules characterization in this population is of paramount importance. Herein, we investigate the value of dual-point 18F-FCH PET/CT in the diagnosis of thyroid cancer in patients referred for pHPT imaging who have thyroid nodules. PATIENTS AND METHODS: All pHPT patients who underwent a dual-time point 18F-FCH PET/CT (at 5 and 60 minutes postinjection) between July 2019 and December 2020 were analyzed. Only those with a thyroid nodule greater than 10-mm and pathological analysis (criterion standard) were included. Nodule-to-thyroid SUVmax ratio was calculated at the 2 study points, as well as the 18F-FCH washout index (WO%). RESULTS: Twenty-seven patients (32 nodules) were included in this study. The final diagnoses were as follows: 27 benign nodules including 2 NIFTPs (noninvasive follicular thyroid neoplasm with papillary-like nuclear features) and 5 cancers of follicular origin. Early uptake ratio was significantly higher in malignant lesions than in benign nodules (P = 0.0008). Thyroid cancers were also characterized by a marked 18F-FCH washout index (WO% benign vs cancer: 2.9% ± 4.1% vs 45.5% ± 13.4%, P = 0.0001). Using a WO% threshold of 22.1%, 25/27 benign nodules and 5/5 malignant lesions were accurately classified (sensitivity of 100%, specificity of 92.6%, positive predictive value of 71.4%, and negative predictive value of 100%). The false-positive findings were related to the 2 NIFTPs that share similarities with thyroid cancer. CONCLUSIONS: Our preliminary results suggest to perform a dual-time-point PET/CT acquisition protocol in pHPT patients with uncharacterized centimeter thyroid nodules. However, the real impact of these promising results should be assessed by prospective studies on a larger cohort of patients.
引用
- Bani J, Morland D, Hubelé F, et al. Dual-Time-Point 18F-Fluorocholine PET/CT Improves Characterization of Thyroid Nodules in Patients Referred for Primary Hyperparathyroidism: A Proof of Concept Study. Clin Nucl Med. 2021. PMID: 34524168. doi:10.1097/RLU.0000000000003904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。